Evidence for cost reduction based on pre-admission MRSA screening in general surgery
- PMID: 17692566
- DOI: 10.1016/j.ijheh.2007.06.001
Evidence for cost reduction based on pre-admission MRSA screening in general surgery
Abstract
Colonization with methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for MRSA infection causing increased costs in patient's care and treatment. To evaluate cost efficiency, pre-admission MRSA screening and subsequent MRSA decolonization of patients admitted to the Department of General Surgery at the University Hospital of Münster were determined. In 2004, 2054 (89.3%) out of the total of 2299 hospital-admitted patients were screened for MRSA (1769 elective and 530 direct admissions); 1536 patients underwent pre-admission MRSA screening (86.8% of the 1769 elective admissions), of whom seven patients (0.5%) were MRSA-positive and five of these were successfully decolonized before admission. In case of direct admissions, i.e., emergency cases or transferral from other hospitals, 2.4% and 8.6% were MRSA-positive, respectively. There were 25 patients MRSA positive during their hospital stay, two of these were nosocomially acquired, which represent 0.1 nosocomial MRSA cases in 1000 in-patients. The average MRSA carrier was (65+/-15 years) older than the other patients (55+/-17 years), had a significantly higher rate of pulmonary disease, coronary heart disease and certain infections; and had a longer hospital stay (27 versus 10 days, p<0.05). The total costs of the MRSA screening were approximately 20,000 euro. Since the estimated costs for handling MRSA treatment and isolation during a hospital stay are 6000-10,000 euro for each affected patient, we estimated that approximately 20,000 euro could be saved by detecting and successfully decolonizing a total of five patients through pre-admission screening. In this calculation, additional costs due to the increased morbidity and mortality of MRSA carriers and the possible spread of MRSA through unrecognized colonization were not included. In conclusion, pre-admission screening for MRSA is an effective method to reduce the hospital burden of MRSA-colonized patients and the savings due to consistent decolonization before elective admission outweigh the costs of screening.
Similar articles
-
Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in adult emergency admissions--a case for screening all patients?J Hosp Infect. 2007 May;66(1):15-21. doi: 10.1016/j.jhin.2007.01.013. Epub 2007 Mar 21. J Hosp Infect. 2007. PMID: 17376560
-
Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment.Clin Microbiol Infect. 2005 Jun;11(6):466-71. doi: 10.1111/j.1469-0691.2005.01153.x. Clin Microbiol Infect. 2005. PMID: 15882196
-
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections.Clin Microbiol Infect. 2005 Jun;11(6):457-65. doi: 10.1111/j.1469-0691.2005.01152.x. Clin Microbiol Infect. 2005. PMID: 15882195
-
Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?J Hosp Infect. 2001 Jan;47(1):9-18. doi: 10.1053/jhin.2000.0873. J Hosp Infect. 2001. PMID: 11161895 Review.
-
[Meticillin-resistant Staphylococcus aureus: incidence, risk factors and interest of systematic screening for colonization in intensive-care unit].Ann Fr Anesth Reanim. 2006 Jun;25(6):626-32. doi: 10.1016/j.annfar.2006.01.016. Epub 2006 Mar 20. Ann Fr Anesth Reanim. 2006. PMID: 16546345 Review. French.
Cited by
-
Cost comparison of MRSA screening and management - a decision tree analysis.BMC Health Serv Res. 2012 Dec 1;12:438. doi: 10.1186/1472-6963-12-438. BMC Health Serv Res. 2012. PMID: 23198880 Free PMC article.
-
Microbiological, Clinical and Radiological Aspects of Diabetic Foot Ulcers Infected with Methicillin-Resistant and -Sensitive Staphylococcus aureus.Pathogens. 2022 Jun 17;11(6):701. doi: 10.3390/pathogens11060701. Pathogens. 2022. PMID: 35745555 Free PMC article.
-
Unexpected Multidrug Resistance of Methicillin-Resistant Staphylococcus aureus in Urine Samples: A Single-Center Study.Korean J Urol. 2014 May;55(5):349-53. doi: 10.4111/kju.2014.55.5.349. Epub 2014 May 12. Korean J Urol. 2014. PMID: 24868340 Free PMC article.
-
MRSA screening in the vascular day-case population.Ann R Coll Surg Engl. 2011 Jan;93(1):44-8. doi: 10.1308/003588410X12771863937043. Epub 2010 Sep 22. Ann R Coll Surg Engl. 2011. PMID: 20863425 Free PMC article.
-
Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.Pharmacoeconomics. 2015 Apr;33(4):285-325. doi: 10.1007/s40273-014-0242-y. Pharmacoeconomics. 2015. PMID: 25447195 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical